DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Fitchett D, Zinman B, Wanner C. et al
Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial.
Eur Heart J 2016;
37: 1526-1534 . doi:10.1093/eurheartj/ehv728
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.